Scientists have developed a nasal "molecular shield" that disarms pollen, blocking allergic reactions fast without the use of ...

Pollen levels have been so high this year that hay fever has been triggered in non-sufferers. The Copernicus Atmosphere ...

Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...

Female permanent night shift workers have higher odds of moderate-to-severe asthma than female day workers, but this relationship is not seen in men.

The global house dust mite allergy treatment market size was US$ 1.5 billion in 2021. The global house dust mite allergy treatment market size is forecast to reach US$ 4.6 billion by 2030, growing at ...

Waking up congested, or sneezing through the night? These hypoallergenic bedding picks will help you get an allergy-free night's sleep. Shop online ...

But there's an even greater threat looming on the horizon: thunderstorm asthma. This extreme weather phenomenon literally ...

Asthma isn’t all about medication, as it’s also about having a healthy and safe environment, both inside and outside. From ...

A new food allergy diagnostic test addresses many of the drawbacks of the current gold standard oral food challenge by only ...

Doctors and patients should rigorously evaluate diagnosis and treatment compliance before turning to biologics, two ...

Increasing environmental events driven by climate change and human activity exacerbate allergy and asthma conditions, further compounded by exposure to persistent pollutants like per-and ...

Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...